Skip to content
PLEASE DONATE Now To Help Get the THIRD Clinical Trial Going!
agt-logo-redirect-page

Menu

  • AGT Investors
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
  • Technology
    • Overview
    • Rapid Drug Development
    • Genetic Technologies
    • Gamma Delta T Cell Therapy For Cancer – ImmunoTox
  • Resources
    • Blog
    • Newsletters
    • Videos & Audio
    • HIV Cure Countdown
    • The Cure Chronicles
    • DNA Valley
    • Learning for Young Minds
    • AGT Knowledge Base
    • AGT Patents
  • Media
    • News Releases
    • In The News
    • Online Newsroom
  • About Us
    • Overview
    • Leadership Team
    • Scientific & Clinical Advisors
    • In Memoriam: Dr. Roscoe Brady
    • History
    • Contact Us
  • Careers
  • Donations

Methods of Producing Cells Resistant to HIV Infection

Read More

Non-Integrating Viral Delivery System and Methods of Use Thereof

Read More

HIV Pre-Immunization and Immunotherapy JP

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients KR

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More
« Newer Posts
Older Posts »

Follow AGT on Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

AGT on Facebook

This message is only visible to admins.
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Error: Error validating access token: The session has been invalidated because the user changed their password or Facebook has changed the session for security reasons. Type: OAuthException

Get In Touch

American Gene Technologies Inc.

9717 Key West Ave, Suite 101, Rockville, MD 20850

Phone: (301) 337-2100

Follow Us on Social Media

Contact Us

Sign-up For Our Newsletter

We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.

Sign-up For Our Newsletter

We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.

Sign-Up For Our Newsletter

Follow Us on Social Media

Investors

  • Corporate Profile
  • Schedule Investor Relations Appointment
  • +1 (410)-703-7300

Pipeline

  • Overview
  • HIV
  • Phenylketonuria (PKU)
  • Immuno-Oncology

Technology

  • Overview
  • Rapid Drug Development
  • Genetic Technologies
  • Gamma Delta T Cell Therapy For Cancer – ImmunoTox

Media

  • In The News
  • AGT Newsletters
  • Videos & Audio
  • Gene and Cell Therapy for Young Minds
  • News Releases
  • Blog

About Us

  • Overview
  • Leadership Team
  • Scientific & Clinical Advisors
  • In Memoriam: Dr. Roscoe Brady
  • History
  • Careers
  • Contact Us

Have a question? Visit our knowledge base for instant and current answers.

Copyright © 2025 American Gene Technologies® | Privacy Policy

  • AGT Investors
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
    • Back
  • Technology
    • Overview
    • Rapid Drug Development
    • Genetic Technologies
    • Gamma Delta T Cell Therapy For Cancer – ImmunoTox
    • Back
  • Resources
    • Blog
    • Newsletters
    • Videos & Audio
    • HIV Cure Countdown
    • The Cure Chronicles
    • DNA Valley
    • Learning for Young Minds
    • AGT Knowledge Base
    • AGT Patents
    • Back
  • Media
    • News Releases
    • In The News
    • Online Newsroom
    • Back
  • About Us
    • Overview
    • Leadership Team
    • Scientific & Clinical Advisors
    • In Memoriam: Dr. Roscoe Brady
    • History
    • Contact Us
    • Back
  • Careers
  • Donations
  • Search
Scroll To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy